Jiman Kim1, A Ri Byun2, Seungwon Kwon3. 1. Kyunghee-saeng Korean Medicine Clinic, Seoul, Republic of Korea. 2. Department of Family Medicine, Ewha Womans University Mokdong Hospital, Seoul, Republic of Korea. 3. Department of Cardiovascular and Neurologic Diseases, College of Korean Medicine, KyungHee University, Seoul, Republic of Korea. Electronic address: kkokkottung@hanmail.net.
Abstract
INTRODUCTION: Diabetes mellitus has significant effects on the human body. Recently, herbal medicines have received attention as complementary anti-diabetic agents on the basis of the results of several experimental studies. We present a series of 38 cases that demonstrate the positive effect of Yeonryeonggobon-dan (YRGBD), an herbal complex, in lowering blood sugar levels in patients with uncontrolled type 2 diabetes mellitus. METHODS: We reviewed the medical records of 38 patients treated with YRGBD. The types and doses of other hypoglycemic agents administered to the patients remained unchanged during treatment with YRGBD. RESULTS: After YRGBD therapy, the glycated haemoglobin level decreased from 76.16±19.90mmol/mol (9.11±1.82%) to 51.21±8.82mmol/mol (6.84±0.81%). There was a statistically significant difference between the glycated haemoglobin levels measured before and after treatment (paired t test, p<0.001). DISCUSSION: In the present study, we show the clinical effects of YRGBD on blood sugar control in patients with type 2 diabetes mellitus. Further clinical studies investigating the effects of YRGBD are needed.
INTRODUCTION:Diabetes mellitus has significant effects on the human body. Recently, herbal medicines have received attention as complementary anti-diabetic agents on the basis of the results of several experimental studies. We present a series of 38 cases that demonstrate the positive effect of Yeonryeonggobon-dan (YRGBD), an herbal complex, in lowering blood sugar levels in patients with uncontrolled type 2 diabetes mellitus. METHODS: We reviewed the medical records of 38 patients treated with YRGBD. The types and doses of other hypoglycemic agents administered to the patients remained unchanged during treatment with YRGBD. RESULTS: After YRGBD therapy, the glycated haemoglobin level decreased from 76.16±19.90mmol/mol (9.11±1.82%) to 51.21±8.82mmol/mol (6.84±0.81%). There was a statistically significant difference between the glycated haemoglobin levels measured before and after treatment (paired t test, p<0.001). DISCUSSION: In the present study, we show the clinical effects of YRGBD on blood sugar control in patients with type 2 diabetes mellitus. Further clinical studies investigating the effects of YRGBD are needed.
Authors: Chan-Sik Kim; Junghyun Kim; Young Sook Kim; Kyuhyung Jo; Yun Mi Lee; Dong Ho Jung; Ik Soo Lee; Joo-Hwan Kim; Jin Sook Kim Journal: Nutrients Date: 2019-03-04 Impact factor: 5.717